Status:
UNKNOWN
Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
Lead Sponsor:
Samsung Medical Center
Conditions:
Lung Cancer
Eligibility:
All Genders
21+ years
Brief Summary
The next generation of personalized medical treatment according to the type of personal genetic information are evolving rapidly. The genome analysis needs systematic infra and database based on perso...
Detailed Description
To determine the feasibility of the use of tumor's molecular profiling and targeted therapies in the treatment of advanced cancer and to determine the clinical outcome(PFS, duration of response and ov...
Eligibility Criteria
Inclusion
- metastatic, histologically confirmed NSCLC, head \& Neck Cancer, Esophageal cancer
Exclusion
- \-
Key Trial Info
Start Date :
November 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02299622
Start Date
November 1 2013
End Date
December 1 2023
Last Update
March 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea